Syntara Ltd
Syntara Limited operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia. Its lead product candidate, amsulostat, is being developed for the treatment of bone marrow cancer myelofibrosis and i… Read more
Syntara Ltd (SNT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.694x
Based on the latest financial reports, Syntara Ltd (SNT) has a cash flow conversion efficiency ratio of -0.694x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.12 Million) by net assets (AU$16.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Syntara Ltd - Cash Flow Conversion Efficiency Trend (2004–2023)
This chart illustrates how Syntara Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Syntara Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Syntara Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Companhia de Gás de São Paulo - COMGÁS
SA:CGAS3
|
0.555x |
|
The Farmers Bank of Appomattox
OTCQB:FBPA
|
N/A |
|
Hep Tech Co Ltd
TWO:3609
|
-0.082x |
|
Deniz Gayrimenkul Yatirim Ortakligi AS
IS:DZGYO
|
0.068x |
|
Cipherlab Co Ltd
TWO:6160
|
-0.005x |
|
TERACT EO 1
F:6O8
|
N/A |
|
SPSoft Inc.
KQ:443670
|
0.018x |
|
Highlands REIT Inc
OTCGREY:HHDS
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Syntara Ltd (2004–2023)
The table below shows the annual cash flow conversion efficiency of Syntara Ltd from 2004 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-06-30 | AU$9.56 Million | AU$-7.28 Million | -0.761x | +49.55% |
| 2022-06-30 | AU$10.80 Million | AU$-16.30 Million | -1.509x | -239.75% |
| 2021-06-30 | AU$2.85 Million | AU$3.07 Million | 1.080x | +111.63% |
| 2020-06-30 | AU$1.43 Million | AU$-13.28 Million | -9.283x | -594.61% |
| 2019-06-30 | AU$14.81 Million | AU$-19.80 Million | -1.336x | -221.73% |
| 2018-06-30 | AU$11.12 Million | AU$12.21 Million | 1.098x | +125.33% |
| 2017-06-30 | AU$3.52 Million | AU$-15.26 Million | -4.335x | -656.57% |
| 2016-06-30 | AU$20.93 Million | AU$-11.99 Million | -0.573x | -195.54% |
| 2015-06-30 | AU$36.32 Million | AU$21.78 Million | 0.600x | +138.51% |
| 2014-06-30 | AU$18.07 Million | AU$-28.13 Million | -1.557x | -198.78% |
| 2013-06-30 | AU$67.89 Million | AU$-35.38 Million | -0.521x | -50.03% |
| 2012-06-30 | AU$109.80 Million | AU$-38.14 Million | -0.347x | +34.15% |
| 2011-06-30 | AU$70.83 Million | AU$-37.37 Million | -0.528x | -52.90% |
| 2010-06-30 | AU$115.02 Million | AU$-39.68 Million | -0.345x | -79.48% |
| 2009-06-30 | AU$137.69 Million | AU$-26.47 Million | -0.192x | -21.48% |
| 2008-06-30 | AU$119.12 Million | AU$-18.85 Million | -0.158x | +41.47% |
| 2007-06-30 | AU$76.56 Million | AU$-20.70 Million | -0.270x | -94.07% |
| 2006-06-30 | AU$98.89 Million | AU$-13.78 Million | -0.139x | +46.58% |
| 2005-06-30 | AU$35.57 Million | AU$-9.27 Million | -0.261x | -50.10% |
| 2004-06-30 | AU$26.78 Million | AU$-4.65 Million | -0.174x | -- |